Trial Profile

Exogenous Surfactant in Very Preterm Neonates Presenting With Severe Respiratory Distress in Prevention of Bronchopulmonary Dysplasia

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 26 Aug 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Poractant alfa (Primary)
Indications Bronchopulmonary dysplasia
Focus Therapeutic Use
Acronyms CURDYS

Most Recent Events

23 Aug 2022 Status changed from active, no longer recruiting to completed.
08 Sep 2021 Planned End Date changed from 1 Jun 2021 to 1 Jun 2022.
24 Sep 2020 This trial is completed (Global End Date: 20 May 2020), according to European Clinical Trials Database record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com